This article is authored by Urvee Garg, director, HAB Pharma.

In the United States, the patent protection process as it relates to the drug industry has been distorted by the political system, intense lobbying and large campaign contributions. The result has ...

When an employee conceives of a new innovation, a business is often confronted with a difficult decision — whether to apply for patent protection on the innovation or whether to keep the innovation ...

“The tension between patents and trade dress protection is most evident when the alleged trade dress (or aspects thereof) has been disclosed in a utility patent.” Patents and trademarks protect ...

As anyone who follows technology is aware, ChatGPT has made one of the biggest splashes in the innovation pool in recent memory. It has already had a profound effect on the software space as the ...

Opinions expressed by Entrepreneur contributors are their own. There was a time when inventors did not have to worry about protecting intellectual property outside their country, largely because ...

This week on IPWatchdog Unleashed we will explore the age-old question about whether it is best to keep an innovation as a trade secret or if it makes sense to seek patent protection. And while this ...

Don’t sleep on AbbVie’s recent federal court victory which upheld its patents on big-selling cancer drug Imbruvica, warns one influential biopharma analyst. In the case, Delaware judge Colm Connolly ...

In a perfect world, the system for conveying medications from their makers to patients should be designed to deliver the lowest-cost drugs. The system in the U.S. doesn’t even come close. Insurers ...

A federal appeals court in Washington, D.C., reversed Boston Scientific’s $42 million stent patent verdict, shifting leverage ...